Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: KERENDIA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Kerendia (finerenone) submitted by Bayer HealthCare Pharmaceuticals Inc. The action concerns the regulatory appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kerendia (finerenone)

Snippet

SUPPL AP for KERENDIA (FINERENONE)